Lower or higher blood-pressure targets for high-risk patients?

被引：0

作者：

Alberto Zanchetti

机构：

[1] Alberto Zanchetti is at the Istituto Auxologico Italiano (IRCCS) and Centro Interuniversitario di Fisiologia Clinica e Ipertensione,

[2] Università degli Studi di Milano,undefined

[3] Via Ariosto 13,undefined

[4] 20145 Milan,undefined

[5] Italy.,undefined

来源：

Nature Reviews Cardiology | 2016年 / 13卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Blood-pressure lowering has undisputable benefits, but the optimal values to which blood pressure should be lowered are debated. Interpretation of recent trials is controversial, and post-hoc analyses to investigate the inflection point of the curve relating events to blood pressure are disputed. Meta-analyses of randomized trials and prospective, cohort studies might guide decision-making.

引用

页码：637 / 638

页数：1

共 12 条

[1]

Thomopoulos C(2014)Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials J. Hypertens. 32 2285-2295

[2]

Parati G(2009)When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal J. Hypertens. 27 923-934

[3]

Zanchetti A(2013)2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J. Hypertens. 31 1281-1357

[4]

Zanchetti A(2014)2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 507-520

[5]

Grassi G(2016)Effects of blood pressure lowering on outcome incidence in hypertension. 7. Effects of more versus less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials J. Hypertens. 34 613-622

[6]

Mancia G(2014)Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial J. Hypertens. 32 1888-1897

[7]

Mancia G(undefined)undefined undefined undefined undefined-undefined

[8]

James PA(undefined)undefined undefined undefined undefined-undefined

[9]

Thomopoulos C(undefined)undefined undefined undefined undefined-undefined

[10]

Parati G(undefined)undefined undefined undefined undefined-undefined

← 1 2 →